XML 52 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
In Millions, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Operating cash flows:    
Net income before non-controlling interests $ 456 $ 424
Adjustments to reconcile net income to cash provided by operations:    
Depreciation and amortization of fixed assets and capitalized software 75 69
Amortization of intangible assets 22 18
Adjustments to acquisition related contingent consideration liability (6) 1
Provision for deferred income taxes 59 51
Gain on investments (13) (21)
Loss on disposition of assets 1 2
Share based compensation expense 33 42
Changes in assets and liabilities:    
Net receivables (150) (120)
Other current assets (35) (54)
Other assets 33 (14)
Accounts payable and accrued liabilities 47 53
Accrued compensation and employee benefits (764) (727)
Accrued income taxes 28 39
Contributions to pension and other benefit plans in excess of current year expense/credit (93) (350)
Other liabilities (85) (42)
Effect of exchange rate changes 12 36
Net cash used for operations (380) (593)
Financing cash flows:    
Purchase of treasury shares (100) (100)
Net increase in commercial paper 100 0
Proceeds from debt 0 50
Repayments of debt (3) (252)
Shares withheld for taxes on vested units – treasury shares (49) (65)
Issuance of common stock from treasury shares 92 135
Payments of contingent consideration for acquisitions (20) (3)
Distributions of non-controlling interests (1) (2)
Dividends paid (137) (127)
Net cash used for financing activities (118) (364)
Investing cash flows:    
Capital expenditures (99) (88)
Net sales of long-term investments 0 92
Proceeds from sales of fixed assets 1 1
Dispositions 0 3
Acquisitions (319) (1)
Other, net 1 1
Net cash (used for) provided by investing activities (416) 8
Effect of exchange rate changes on cash and cash equivalents (9) (89)
Decrease in cash and cash equivalents (923) (1,038)
Cash and cash equivalents at beginning of period 2,303 2,301
Cash and cash equivalents at end of period $ 1,380 $ 1,263